| After the 21st century,the survival environment of Chinese pharmaceutical enterprises have undergone a huge changes.After entering the WTO,Chinese pharmaceutical market is gradually opening.Different competitive factors are existing at the same time.They are include the huge quantities of pharmaceutical enterprises,the technology monopoly and market share in foreign company,the reformation of national health policy and the medicine centralized bid procurement etc.The profit of Chinese Pharmaceutical companies is declining more and more.They are confronting an unprecedented competition now.Therefore,how to gain a competitive advantage and keep the company development had become the most important task for these enterprises.At present,the study about the core competitiveness for pharmaceutical enterprises is short.So the study about the core competence of Harbin general pharm.factory has a significant sense.This article has combined the core competence theory with enterprise management.It introduced the present situation of General Pharm.Factory.After a huge investigation,the dissertation analysed the company ' s production capacity,the information system,the current situation of marketing channel and the brand influence etc.The paper also has listed the core competence of PFIZER,GLAXOSMITHKLINE,TAKEDA,ZHUHAI UNITED LABORATORIES,XI AN JANSSEN and QILU PHARMA.After that,the paper had discussed cultivated method of the competence for General Pharm.Factory.They are include development of human resource management,the enhancement of marketing management,the comprehensive innovation,the development of international quality certification and the improvement of international trade.Finally,this paper proposes five safeguard measures for Harbin General Pharmaceutical Factory to cultivating the core competence.It establish the practical and theoretical basis for the cultivation of core competitiveness of Harbin General Pharmaceutical Factory. |
PDF Full Text Request